home / stock / phio / phio news


PHIO News and Press, Phio Pharmaceuticals Corp. From 07/19/21

Stock Information

Company Name: Phio Pharmaceuticals Corp.
Stock Symbol: PHIO
Market: NASDAQ
Website: phiopharma.com

Menu

PHIO PHIO Quote PHIO Short PHIO News PHIO Articles PHIO Message Board
Get PHIO Alerts

News, Short Squeeze, Breakout and More Instantly...

PHIO - Phio Pharmaceuticals Corp.: The Losing Streak Continues (PHIO)

Shares of Phio Pharmaceuticals Corp. (NASDAQ:PHIO) traded today at $1.72, breaking its 52-week low. This new low was reached on below average trading volume as 166,000 shares traded hands, while the average 30-day volume is approximately 417,000 shares. Potential upside of 65.3% exists f...

PHIO - Phio Pharmaceuticals Scheduled to Participate in a Fireside Chat with H.C. Wainwright on July 12th

Phio Pharmaceuticals Scheduled to Participate in a Fireside Chat with H.C. Wainwright on July 12th PR Newswire MARLBOROUGH, Mass. , July 7, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of i...

PHIO - Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th

Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th PR Newswire MARLBOROUGH, Mass. , June 22, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-...

PHIO - Phio Pharmaceuticals Scheduled to Participate in Two Upcoming Investor Events in June

Phio Pharmaceuticals Scheduled to Participate in Two Upcoming Investor Events in June PR Newswire MARLBOROUGH, Mass. , June 14, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-o...

PHIO - Phio Pharmaceuticals Presents New In Vivo Data at the 2021 ASCO Annual Meeting Showing Dual-Targeting INTASYL Offers Increased Efficacy and Safety Potential Over Other Therapeutic Approaches

Phio Pharmaceuticals Presents New In Vivo Data at the 2021 ASCO Annual Meeting Showing Dual-Targeting INTASYL Offers Increased Efficacy and Safety Potential Over Other Therapeutic Approaches Treatment with INTASYL dual-targeting BRD4 and PD-1, elicits complete tumor responses an...

PHIO - Phio Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update

Phio Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update PR Newswire MARLBOROUGH, Mass. , May 13, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of ...

PHIO - Phio Pharma's PH-762 shows antitumor activity in HER2-targeted CAR-T cells in solid tumors in mice

Phio Pharmaceuticals (PHIO) announces positive new in vivo data showing that PH-762 significantly enhanced the antitumor efficacy of HER2-targeted CAR-T cells (HER2CART) in solid tumors.A statistically significant and durable inhibition of tumor growth was seen in PH-762-treated HER2CART cell...

PHIO - DDD, IGT, EFC and FF among notable premarket movers

Intec Pharma (NTEC) +25%.Ferro Corporation (FOE) +23% on Q1 results.Cerecor (CERC) +15% as FDA grants fast track designation to its CERC-002.FutureFuel Corp. (FF) +14% on special dividend.Larimar Therapeutics (LRMR) +13% on Q1 results.Advanced Emissions Solutions (ADES) +1...

PHIO - Phio Pharmaceuticals Presents Positive In Vivo Data at ASGCT Showing PH-762 Significantly Enhanced Antitumor Efficacy of HER2-Targeted CAR-T Cells

Phio Pharmaceuticals Presents Positive In Vivo Data at ASGCT Showing PH-762 Significantly Enhanced Antitumor Efficacy of HER2-Targeted CAR-T Cells Data provide proof-of-concept for the application of INTASYL compounds as a way to unlock the potential of CAR-T cell therapy in sol...

PHIO - 4 Hot Reddit Penny Stocks With Higher Than Average Volume

Why These Reddit Penny Stocks Could Be Worth Watching Investors looking to make sizable gains in a short time frame often turn to penny stocks. These low-cost stocks have the potential to generate a large profit in a short time frame due to the inherent high volatility. For the same...

Previous 10 Next 10